Nicholas A. Smith

Array ( [id] => 8772191 [patent_doc_number] => 08426144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Monocyte-derived nucleic acids and related compositions and methods' [patent_app_type] => utility [patent_app_number] => 13/239169 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9171 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13239169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719851 [patent_doc_number] => 20120009186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'FcGammaRIIB Specific Antibodies and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/238942 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 67196 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009186.pdf [firstpage_image] =>[orig_patent_app_number] => 13238942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346827 [patent_doc_number] => 20120207758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'CD22 Exon 12 Deletion Mutants' [patent_app_type] => utility [patent_app_number] => 13/230843 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14444 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094115 [patent_doc_number] => 20120082664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'OPTIMIZED ANTIBODIES THAT TARGET CD19' [patent_app_type] => utility [patent_app_number] => 13/221811 [patent_app_country] => US [patent_app_date] => 2011-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 48127 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082664.pdf [firstpage_image] =>[orig_patent_app_number] => 13221811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10002434 [patent_doc_number] => 09046513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Dual variable domain immunoglobulins and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/217937 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 98141 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9053992 [patent_doc_number] => 20130251706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 - SPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/817744 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 24138 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15512781 [patent_doc_number] => 10562966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Antibodies of the class IGG4 [patent_app_type] => utility [patent_app_number] => 13/817961 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 40 [patent_no_of_words] => 19854 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8915931 [patent_doc_number] => 20130177555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'Monomeric Polypeptides Comprising Variant FC Regions And Methods Of Use' [patent_app_type] => utility [patent_app_number] => 13/814657 [patent_app_country] => US [patent_app_date] => 2011-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26115 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381440 [patent_doc_number] => 20120225066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/197731 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34817 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766039 [patent_doc_number] => 20120034160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/196138 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 108639 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034160.pdf [firstpage_image] =>[orig_patent_app_number] => 13196138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273709 [patent_doc_number] => 08637641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Antibodies with modified isoelectric points' [patent_app_type] => utility [patent_app_number] => 13/194904 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 42 [patent_no_of_words] => 31538 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13194904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8883581 [patent_doc_number] => 20130156765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/812269 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 31950 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413360 [patent_doc_number] => 08697396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Modulation of antibody effector function by hinge domain engineering' [patent_app_type] => utility [patent_app_number] => 13/190199 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 59464 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13190199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990582 [patent_doc_number] => 20130217863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'Method to Improve Glycosylation Profile and to Induce Maximal Cytotoxicity for Antibody' [patent_app_type] => utility [patent_app_number] => 13/811134 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 17736 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776358 [patent_doc_number] => 20120039907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'POLYPEPTIDES INCLUDING MODIFIED CONSTANT REGIONS' [patent_app_type] => utility [patent_app_number] => 13/186421 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9666 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039907.pdf [firstpage_image] =>[orig_patent_app_number] => 13186421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814169 [patent_doc_number] => 20130115215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'DOMAIN INSERTION IMMUNOGLOBULIN' [patent_app_type] => utility [patent_app_number] => 13/809577 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13952 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656445 [patent_doc_number] => 20110305714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 13/182209 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 78732 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305714.pdf [firstpage_image] =>[orig_patent_app_number] => 13182209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731557 [patent_doc_number] => 20120014957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/178641 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 88593 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014957.pdf [firstpage_image] =>[orig_patent_app_number] => 13178641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586365 [patent_doc_number] => 20110280875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'ANTIBODIES WHICH BIND HUMAN CXCR3' [patent_app_type] => utility [patent_app_number] => 13/170233 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19853 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280875.pdf [firstpage_image] =>[orig_patent_app_number] => 13170233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669080 [patent_doc_number] => 20110318349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/167323 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 75730 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167323 [rel_patent_id] =>[rel_patent_doc_number] =>)